8/103 sources · 2 publishersUpdated Oct 28, 23:36 UTC
Teladoc reports narrower Q3 loss and raises full-year outlook
Teladoc Health reported a third-quarter loss of -$0.15 per share and revenue of $605.1M, beating estimates, on October 28, 2026. Adjusted EBITDA increased 14% year over year to $79.4M. The company raised full-year guidance to revenue of $2.4B to $2.44B and a loss of -$0.75 to -$0.95 per share.
Why it matters
The narrower quarterly loss and higher full-year outlook provide investors with updated earnings and revenue ranges. Teladoc's improved adjusted EBITDA indicates stronger profitability despite the reported revenue decline.
Key facts
- 1Teladoc reported a third-quarter loss of -$0.15 per share versus an estimated -$0.22 per share loss. investing.com
- 2Third-quarter revenue was $605.1M. investing.com
- 3Adjusted EBITDA rose 14% year over year to $79.4M. investing.com
- 4Full-year guidance calls for revenue of $2.4B to $2.44B and a loss of -$0.75 to -$0.95 per share. investing.com
- 5BetterHelp revenue declined 13% year over year. investing.com
Open questions
- The reported third-quarter revenue estimate differs across materials: $585.5M in material 1 and $588.44M in material 2.
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.